Skip to main content
FDA gives orphan status to J&J's pediatric drug for C. diff infection
8/10/2017

Johnson & Johnson's cadazolid, for the treatment of pediatric patients with Clostridium difficile infection, has been granted orphan drug status by the FDA.

Full Story: